Impact of tourniquet application on postoperative delirium in elderly patients undergoing total knee arthroplasty: a randomized clinical trial

止血带应用对老年全膝关节置换术后谵妄的影响:一项随机临床试验

阅读:1

Abstract

BACKGROUND: Tourniquet is widely used in total knee arthroplasty (TKA), but its impact on postoperative delirium (POD) remains unclear. The purposes of this study were to investigate the impact of tourniquet application on POD in elderly patients TKA and to explore the possible mechanisms associated with POD. MATERIALS AND METHODS: In this prospective, single-center randomized clinical trial study, 313 patients scheduled for single TKA under general anesthesia were randomly assigned to groups with or without a limb tourniquet. The primary outcome was the incidence of POD within postoperative 7 days. Secondary outcomes were the levels of hypoxia-inducible factor-1α (HIF-1α), tumor necrosis factor-alpha, superoxide dismutase (SOD), and S100β protein (S100β) measured postoperative 30 minutes and 24 hours, blood loss, pain score, the time to first postoperative ambulation, postoperative hospitalization, postoperative complications, and adverse events. RESULTS: The incidence of POD in tourniquet group was significantly higher than that in no tourniquet group (19.1% vs. 9.6%, relative risk 1.12, 95% confidence interval: 1.02-1.23, P = 0.018). The serum level of HIF-1α was higher at postoperative 30 minutes and 24 hours and SOD was lower at postoperative 24 hours in tourniquet group compared with no tourniquet group. The incidence of postoperative complications and adverse events were comparable in both groups. CONCLUSION: We concluded that tourniquet application during TKA increased the incidence of POD within postoperative 7 days in older patients, and increased serum level of HIF-1α and decreased level of SOD, which indicated that they may be potential targets for preventing and treating POD.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。